Alzheimer's & Dementia
A plasma-based protein signature combining NPTXR, ACHE, and p-tau217 predicts progression to symptomatic Alzheimer's disease
Cohort study in peopleBiomarkers
The paper
Washington University in St. Louis
Alzheimer's & Dementia, 1 Aug 2026



